某三甲医院耐碳青霉烯类铜绿假单胞菌感染患者的临床特征及危险因素
Clinical Characteristics and Risk Factors of Carbapenem-Resistant Pseudomonas Aeruginosa Infection in a Tertiary Hospital
DOI: 10.12677/acm.2025.151237, PDF,    科研立项经费支持
作者: 高 喆:青岛大学青岛医学院,山东 青岛;赵京明*:青岛大学附属医院呼吸与危重症医学科,山东 青岛
关键词: 铜绿假单胞菌耐碳青霉烯类下呼吸道感染临床特征危险因素Pseudomonas Aeruginosa Carbapenem-Resistant Lower Respiratory Tract Infection Clinical Features Risk Factors
摘要: 目的:探讨某三甲医院耐碳青霉烯类铜绿假单胞菌感染患者的临床特征及危险因素。方法:回顾性分析2017年10月~2022年10月某三甲医院住院治疗的52例CRPA患者的临床资料及菌株药敏数据,分析结果差异、临床特征和危险因素。结果:52例CRPA感染患者中,男性38例(73.08%),男女比例为2.7:1;平均年龄65 ± 14岁;科室最常见于呼吸与危重症医学科17例(32.69%),其次是重症医学科12例(23.08%);标本主要来源于痰液40例(76.92%);对于基础疾病,合并贫血患者36例(69.23%),呼吸系统疾病34例(65.38%),心脑血管系统疾病30例(57.69%);近2月抗生素的使用情况,使用碳青霉烯类抗生素的有34例(65.38%);半合成β内酰胺酶复合制剂31例(59.62%);52株CRPA中耐药率 ≥ 50%的抗菌药物从高到低依次为亚胺培南、美洛培南,多粘菌素是耐药率最低且药物敏感率最高的抗菌药物。结论:52例CRPA患者表明男性患者、住院时间过长、合并贫血及呼吸系统疾病、近2月内碳青霉烯类抗菌药物应用史均会增加感染耐药菌的风险,控制危险因素、缩短住院时长以及合理应用抗生素可以减少多重耐药菌感染。
Abstract: Objective: The objective of this study was to investigate the clinical features and risk factors associated with carbapenem-resistant pseudomonas aeruginosa (CRPA) infection in a tertiary hospital. Methods: Retrospective analysis was conducted on the clinical and bacterial susceptibility data of 52 CRPA-infected patients hospitalized from October 2017 to October 2022. Results: Clinical characteristics and risk factors were analyzed for differences. Among the 52 CRPA-infected patients, 38 (73.08%) were male with a male-to-female ratio of 2.7:1. The average age was 65 ± 14 years, the department is most commonly found in the Respiratory and Critical Care Medicine department with 17 cases (32.69%), followed by the Intensive Care Medicine department with 12 cases (23.08%). Sputum was the primary source of infection in 40 cases (76.92%). Underlying diseases included anemia in 36 cases (69.23%), respiratory diseases in 34 cases (65.38%), and cardiovascular/cerebrovascular diseases in 30 cases (57.69%). Within the past two months, carbapenem antibiotics were used by 34 cases (65.38%). Semi-synthetic β-lactamase compound preparations were used by 31 cases (59.62%). Amongst the 52 strains of CRPA, the antibiotics with resistance rate ≥ 50% were imipenem and meropenem from high to low, and polymyxin was the antibiotic with the lowest resistance rate and the highest sensitivity rate. Conclusion: The findings from this study indicate that male gender, longer hospital stays, anemia, respiratory diseases, and recent use of carbapenem antibiotics are all associated with an increased risk of drug-resistant bacterial infections. Controlling these risk factors, reducing hospital stays, and using antibiotics rationally could help mitigate multi-drug resistant bacteria infections.
文章引用:高喆, 赵京明. 某三甲医院耐碳青霉烯类铜绿假单胞菌感染患者的临床特征及危险因素[J]. 临床医学进展, 2025, 15(1): 1778-1784. https://doi.org/10.12677/acm.2025.151237

参考文献

[1] Jabalameli, F., Taki, E., Emaneini, M. and Beigverdi, R. (2018) Prevalence of Metallo-β-Lactamase-Encoding Genes among Carbapenem-Resistant Pseudomonas aeruginosa Strains Isolated from Burn Patients in Iran. Revista da Sociedade Brasileira de Medicina Tropical, 51, 270-276. [Google Scholar] [CrossRef] [PubMed]
[2] Elshafiee, E.A., Nader, S.M., Dorgham, S.M. and Hamza, D.A. (2019) Carbapenem-Resistant Pseudomonas aeruginosa Originating from Farm Animals and People in Egypt. Journal of Veterinary Research, 63, 333-337. [Google Scholar] [CrossRef] [PubMed]
[3] Deshpande, R. and Zou, C. (2020) Pseudomonas aeruginosa Induced Cell Death in Acute Lung Injury and Acute Respiratory Distress Syndrome. International Journal of Molecular Sciences, 21, Article 5356. [Google Scholar] [CrossRef] [PubMed]
[4] 胡付品, 郭燕, 朱德妹, 等. 2021年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2022, 22(5): 521-530.
[5] 医院感染诊断标准(试行) [J]. 现代实用医学, 2003, 15(7): 460-465.
[6] Falcone, M., Tiseo, G., Carbonara, S., Marino, A., Di Caprio, G., Carretta, A., et al. (2023) Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results from a Nationwide Study in Italy (ALARICO Network). Clinical Infectious Diseases, 76, 2059-2069. [Google Scholar] [CrossRef] [PubMed]
[7] 赖汉瑜, 岑丽莲. 无菌体液标本中碳青霉烯类异质性耐药铜绿假单胞菌的危险因素分析[J]. 检验医学与临床, 2023, 20(17): 2552-2556.
[8] 朱仕超, 尹维佳, 张慧, 等. 耐碳青霉烯病原菌所致血流感染的预测因素研究[J]. 华西医学, 2023, 38(3): 346-351.
[9] 聂亚红, 田可港, 孙玉娟, 等. 医院铜绿假单胞菌的临床特征及危险因素分析[J]. 中国抗生素杂志, 2021, 46(6): 611-615.
[10] 王升, 杨金兰. 医院感染耐碳青霉烯类铜绿假单胞菌的危险因素: 基于倾向性评分匹配的回顾性病例对照研究[J]. 感染、炎症、修复, 2023, 24(1): 17-23.
[11] 黄秋兰, 封卫征, 范德平, 等. 多药耐药铜绿假单胞菌感染危险因素的荟萃分析[J]. 中华医院感染学杂志, 2016, 26(5): 970-972.
[12] Campion, M. and Scully, G. (2018) Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation. Journal of Intensive Care Medicine, 33, 647-655. [Google Scholar] [CrossRef] [PubMed]
[13] 邓文, 胡凯, 余静贵. 2017-2018年某院铜绿假单胞菌的临床分布特点及耐药性分析[J]. 实验与检验医学, 2021, 39(1): 134-136.
[14] Cobos-Trigueros, N., Solé, M., Castro, P., Torres, J.L., Hernández, C., Rinaudo, M., et al. (2015) Acquisition of Pseudomonas aeruginosa and Its Resistance Phenotypes in Critically Ill Medical Patients: Role of Colonization Pressure and Antibiotic Exposure. Critical Care, 19, Article No. 218. [Google Scholar] [CrossRef] [PubMed]
[15] 马慧, 陈磊, 康薇, 等. 耐碳青霉烯类铜绿假单胞菌耐药机制及高危因素的研究进展[J]. 广东化工, 2021, 48(12): 110-111.
[16] 荆楠, 贾爱华, 马冰, 等. 耐碳青霉烯铜绿假单胞菌血流感染患者的细菌耐药性、感染风险因素及预后分析[J]. 中国合理用药探索, 2022, 19(11): 84-91.
[17] 王明贵. 广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制: 中国专家共识[J]. 中国感染与化疗杂志, 2017, 17(1): 82-93.
[18] 王锦, 巩霞, 邵明鑫, 等. 医院重症监护病房患者感染耐碳青霉烯类铜绿假单胞菌分布及耐药性分析[J]. 中国消毒学杂志, 2022, 39(9): 694-697.
[19] 宋晓超, 金美娟, 丁蔚. 重症监护室与普通病房碳青霉烯类耐药铜绿假单胞菌医院感染分布与耐药性[J]. 中华医院感染学杂志, 2021, 31(22): 3397-3401.
[20] 杨兴肖, 李锦锦, 王媛, 等. 某肿瘤医院耐碳青霉烯类铜绿假单胞菌下呼吸道感染患者临床特征及危险因素[J]. 中华医院感染学杂志, 2022, 32(16): 2425-2428.
[21] Lee, C., Su, T., Ye, J., Hsu, P., Kuo, A., Chia, J., et al. (2017) Risk Factors and Clinical Significance of Bacteremia Caused by Pseudomonas aeruginosa Resistant Only to Carbapenems. Journal of Microbiology, Immunology and Infection, 50, 677-683. [Google Scholar] [CrossRef] [PubMed]
[22] 苏冬梅, 赵雷, 董琳, 等. 铜绿假单胞菌血流感染67例临床及预后危险因素分析[J]. 安徽医药, 2021, 25(1): 201-204.
[23] Qin, J., Zou, C., Tao, J., Wei, T., Yan, L., Zhang, Y.Z., et al. (2022) Carbapenem Resistant Pseudomonas aeruginosa Infections in Elderly Patients: Antimicrobial Resistance Profiles, Risk Factors and Impact on Clinical Outcomes. Infection and Drug Resistance, 15, 2301-2314. [Google Scholar] [CrossRef] [PubMed]
[24] Terahara, F. and Nishiura, H. (2019) Carbapenem-Resistant Pseudomonas aeruginosa and Carbapenem Use in Japan: An Ecological Study. Journal of International Medical Research, 47, 4711-4722. [Google Scholar] [CrossRef] [PubMed]
[25] 庞彩莲, 刘敏娟, 林景涛, 等. 东莞地区耐碳青霉烯类铜绿假单胞菌的产酶情况及耐药性分析[J]. 海南医学, 2021, 32(21): 2797-2799.
[26] 吴振安, 张亮. 铜绿假单胞菌的临床分布及耐药性分析[J]. 中国临床医生杂志, 2021, 49(1): 55-57.
[27] 黄贤, 金晓东, 王黎斌, 等. 中枢神经康复患者耐碳青霉烯类铜绿假单胞菌血流感染的高危因素及临床特征分析[J]. 中国卫生检验杂志, 2022, 32(19): 2305-2309.